Clinical trial NCT04716972: Evaluating the Impact of COVID-19 (Coronavirus) on Research in Care Homes
Official title: Evaluating the Impact of COVID-19 on Research in Care Homes
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Covid19
Lead sponsor: The Royal Wolverhampton Hospitals NHS Trust
Sponsor class: OTHER_GOV
First posted: 2021-01-20
Enrollment: 7
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Observational model: COHORT
Time perspective: PROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Any staff member working/volunteering in a care home, research staff, residents of care homes, relatives of care home residents, all across the West Midlands are eligible to take part in this research project.

Brief summary: During the COVID-19 (corona virus) pandemic the research arena has had to rapidly adapt and change in order to facilitate and deliver research. The UK (United Kingdom) government and Public Health England have stressed the importance of such research to find solutions to treating, preventing and stopping the spread of COVID-19. Due to national and international 'lock down restrictions' delivering research in care home settings has become even more challenging. The adaptations to conducting consultations have relied heavily on the use of technology, for example video calling, telephone, email, and teleconferencing. It is suggested that the use of technology in care home settings is already a barrier to effective research delivery.

Nevertheless, as care home residents are a vulnerable group, it is critical to include these groups in research in order to enable improved and evidence-based care and their access to new and emerging treatments.

This study aims to assess the opinions and experiences of key stakeholders to identify barriers, and enable better facilitation of research in these settings during and post pandemic.

Detailed description: This two phase project will use a mixed methodology.

Phase one will involve mixed methods surveys. One will be completed by care home residents and the other will be completed by research delivery staff and care home staff.

Phase two will involve qualitative interviews with each of these groups to enable better insight into their views and opinions on research in this area.

Eligibility criteria: Inclusion Criteria:

* Any resident of a care home in the West Midlands
* Any relative/friend of a care home resident in the West Midlands
* Any staff member or volunteer working in care home in the West Midlands
* Any researcher undertaking research in a care home in the West Midlands (during the pandemic or proposed during the pandemic period)

Exclusion Criteria:

* Individuals who are unable to give Informed Consent
* Individuals who lack capacity

Primary outcomes:
measure: Acceptability of vaccine studies in the care home setting through feedback questionnaire with loose themes and no unique measurements.
timeFrame: 6 months
measure: Acceptability of vaccine studies in the care home setting through feedback interview with loose themes and no unique measurements
timeFrame: 6 months
measure: Acceptability of new ways of delivering research through explorative interview with loose themes and no unique measurements
timeFrame: 6 months
measure: Acceptability of new ways of delivering research through explorative questionnaire with loose themes and no unique measurements
timeFrame: 6 months
Secondary outcomes:
Other outcomes:
Locations:
city: Wolverhampton
country: United Kingdom
facility: The Royal Wolverhampton NHS Trust
Study officials:
affiliation: National Institute for Health Research, United Kingdom
name: Kelly Hard
role: PRINCIPAL_INVESTIGATOR
References: